Blog

Tighten your arms, legs, abdomen and buttocks area with a combination of FDA approved #Ultheraprime and Mixto CO2 laser resurfacing and fillers such as #radiesse and #sculptra

For more than a decade, Ultherapy has helped establish microfocused ultrasound with real-time visualization as a leading nonsurgical treatment for mild to moderate skin laxity. Manufacturer-reported experience now exceeds 3.5 million treatments worldwide. The new Ultherapy PRIME platform builds on this history with faster processing, clearer ultrasound imaging and a more efficient treatment experience. Its real-time visualization allows the physician to see beneath the skin and customize energy delivery to the appropriate tissue layers. Ultherapy is FDA-cleared to lift the brow and lax tissue beneath the chin and on the neck, as well as improve lines and wrinkles of the upper chest.

Ultherapy PRIME delivers focused ultrasound energy beneath the skin, initiating the body’s natural collagen-remodeling response without incisions or surgery. The improvement develops gradually, with the brow, jawline and neck often appearing firmer and more defined over the following several months. The treatment can produce natural-looking rejuvenation without changing the patient’s fundamental appearance. Most people can resume normal activities immediately, although temporary redness, swelling, tenderness or tingling may occur. Ultherapy PRIME is faster and may be more comfortable than the original platform, but results and treatment sensations vary, and it is not a replacement for a surgical facelift in patients with substantial skin laxity.